Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
35
SGMO Quote, Financials, Valuation and Earnings
Last price:
$0.44
Seasonality move
:
8.3%
Day range:
$0.43 - $0.45
52-week range:
$0.38 - $2.73
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.36x
P/B ratio:
23.98x
Volume:
2.2M
Avg. volume:
7.5M
1-year change:
-82.2%
Market cap:
$149.7M
Revenue:
$57.8M
EPS (TTM):
-$0.44
Earnings Data
Next earnings date for SGMO
Mar 16
2026
Most recent earnings per share
-$0.11
Missed by $0.01
(Nov 6/2025)
Consensus Estimate
-$0.10
(Nov 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SGMO Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/16/2026 | Q4 | $40.3M | -- | -- | -$0.08 | -- |
| 11/06/2025 | Q3 | $34.4M | $581K | -$0.11 | -$0.10 | -$0.01 |
| 08/07/2025 | Q2 | $31.7M | $18.3M | -$0.08 | -$0.13 | $0.05 |
| 05/12/2025 | Q1 | $7.4M | $6.4M | -$0.14 | -$0.13 | -$0.01 |
| 03/17/2025 | Q4 | $11.7M | $7.6M | -$0.11 | -$0.05 | -$0.06 |
| 11/12/2024 | Q3 | $25.1M | $49.4M | $0.04 | -- | -- |
| 08/06/2024 | Q2 | $8.3M | $356K | -$0.18 | -$0.16 | -$0.02 |
| 05/09/2024 | Q1 | $6.4M | $481K | -$0.27 | -$0.25 | -$0.03 |
| 03/13/2024 | Q4 | $8.1M | $2M | -$0.34 | -- | -- |
| 11/01/2023 | Q3 | -- | -- | -$0.59 | -$0.29 | -$0.30 |
| 08/08/2023 | Q2 | -- | -- | -$0.66 | -$0.32 | -$0.34 |
| 04/26/2023 | Q1 | -- | -- | $0.12 | -$0.26 | $0.38 |
| 02/22/2023 | Q4 | -- | -- | -$0.32 | -$0.36 | $0.04 |
| 11/03/2022 | Q3 | -- | -- | -$0.34 | -$0.36 | $0.02 |
| 08/04/2022 | Q2 | -- | -- | -$0.29 | -$0.34 | $0.05 |
| 05/05/2022 | Q1 | -- | -- | -$0.30 | -$0.29 | -$0.01 |
| 02/24/2022 | Q4 | -- | -- | -$0.26 | -$0.34 | $0.08 |
| 11/04/2021 | Q3 | -- | -- | -$0.33 | -$0.33 | -$0.00 |
| 08/05/2021 | Q2 | -- | -- | -$0.33 | -$0.31 | -$0.02 |
| 05/04/2021 | Q1 | -- | -- | -$0.32 | -$0.29 | -$0.03 |
| 02/24/2021 | Q4 | -- | -- | -$0.29 | -$0.22 | -$0.07 |
| 11/04/2020 | Q3 | -- | -- | -$0.01 | -$0.25 | $0.24 |
| 08/05/2020 | Q2 | -- | -- | -$0.26 | -$0.34 | $0.08 |
| 05/11/2020 | Q1 | -- | -- | -$0.37 | -$0.35 | -$0.02 |
| 02/28/2020 | Q4 | -- | -- | $0.04 | -$0.33 | $0.37 |
| 11/06/2019 | Q3 | -- | -- | -$0.24 | -$0.34 | $0.10 |
| 08/07/2019 | Q2 | -- | -- | -$0.26 | -$0.35 | $0.09 |
| 05/08/2019 | Q1 | -- | -- | -$0.41 | -$0.24 | -$0.17 |
| 02/07/2019 | Q4 | -- | -- | -$0.18 | -$0.23 | $0.05 |
| 11/08/2018 | Q3 | -- | -- | -$0.13 | -$0.18 | $0.05 |
| 08/08/2018 | Q2 | -- | -- | -$0.17 | -$0.15 | -$0.02 |
| 05/08/2018 | Q1 | -- | -- | -$0.23 | -$0.18 | -$0.05 |
| 02/22/2018 | Q4 | -- | -- | -$0.15 | -$0.18 | $0.03 |
| 11/09/2017 | Q3 | -- | -- | -$0.15 | -$0.19 | $0.04 |
| 08/09/2017 | Q2 | -- | -- | -$0.17 | -$0.22 | $0.05 |
| 05/10/2017 | Q1 | -- | -- | -$0.23 | -$0.25 | $0.02 |
| 02/28/2017 | Q4 | -- | -- | -- | -- | -- |
| 10/26/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/03/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/02/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/09/2016 | Q4 | -- | -- | -- | -- | -- |
Sangamo Therapeutics, Inc. Earnings Questions
-
How Much did Sangamo Therapeutics, Inc. Generate in Revenue Last Quarter?
Sangamo Therapeutics, Inc. reported $581K worth of top line sales in its most recent quarter.
-
Did Sangamo Therapeutics, Inc. Beat Earnings Last Quarter?
Sangamo Therapeutics, Inc. announced earnings per share of -$0.11 which represents a miss of analyst forecast a -$0.10 per share.
-
Is Sangamo Therapeutics, Inc. Profitable?
Sangamo Therapeutics, Inc. reported -$1.3M that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Sangamo Therapeutics, Inc. EPS Next Year?
Sangamo Therapeutics, Inc.'s earnings are forecast to decrease from -$0.49 per share to -$0.42 per share next year representing a decrease of -15.57%.
-
When is Sangamo Therapeutics, Inc.'s Earnings Date?
Sangamo Therapeutics, Inc.'s next earnings date is March 16, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
